Venous thromboembollc disease in colorectal patients

Clinics in Colon and Rectal Surgery

Volumn 22, Issue 1, 2009, Pages 34-40

  McNally, Michael P ^a   Burns, Christopher J ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Colorectal surgery; Deep vein thrombosis; Prophylaxis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

EID: 62349084852     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0029-1202884     Document Type: Article

References (48)

1. Hollander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data, Arch Intern Med 2003; 163:1711-1717
2. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study, Arch Intern Med 1991; 151(5):933-938
3. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158(6):585-593
4. Sandier DA, Martin JF, Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82:203-205
5. Seddighzadeh A, Zurawska U, Shetty R, Goldhaber SZ. Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion. Thromb Haemost 2007; 98(6):1220-1225
6. Yu HT, Dylan ML, Lin J, et al, Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007; 64:69-76
7. Virchow RLK, Translation in Matzdorff AC, Bell WR, trans, eds. Thrombosis and embolie (1846-1856), Canton, MA: Science History Publications; 1998,
8. Originally published in German as "Thrombose und Embolie. Gefässentzündung und septische Infektion," Gesammelte Abhandlungen zur wissen-schaftlichen Medicin, Frankfurt am Main: Von Meidinger & Sohn; 1856:219-732
9. Anning ST. The historical aspects of venous thrombosis. Med Hist 1957; 1:28-37
10. Kikura M, Takada T, Sato S. Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS), Thromb Haemost 2004; 91:725-732
11. Geerts WH, Graham FP, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest 2004; 126:338S-400S
12. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA, Wheeler B. Prevention of venous thromboembolism. Chest 2001; 119:132S-175S
13. Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tomour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002; 87:402-408
14. Slender MT, Nielsen TS, Frøkjaer JB, Larsen TB, Lundbye-Christensen S, Thorlacius-Ussing O, High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer. Br J Surg 2007; 94(9):1100-1103
15. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study, Thromb Haemost 2001; 85: 430-434
16. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ, Venous thromboembolism in inflammatory bowel disease. American Journal of Gastroenterology 2004; 99(1):97-101
17. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107(Suppl 1):19-116
18. Nguyen NT, Cronan M, Braley S, Rivers R, Wolfe BM. Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass. Surg Endosc 2003; 17(2): 285-290
19. Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature. Surg Laparosc Endosc 1997; 7:324-331
20. Benko T, Cooke EA, McNally MA, Mollan RAB. Graduated compression stockings: knee length or thigh length. Clin Orthop Relat Res 2001; 383:197-203
21. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Sys Rev 2008; (1):CD001484
22. Prins MH, Hirsh J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity" and venous thromboembolism. Arch Intern Med 1991; 151:1721-1731
23. Ginzburg E, Colin SM, Lopez J, Jackowski J, Brown M, Hameed SMMiami Deep Vein Thrombosis Study Group. Randomized clinical trial of intermittent pneumatic compression and low molecular weight hepann in trauma, Br J Surg 2003; 90(11):1338-1344
24. Geerts WH, Berqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008; 133(suppl):381s-453s
25. Collins R, Scrimgeor A, Yusuf S, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery, N Engl J Med 1988; 318:1162-1173
26. Clagett GP, Reisch JS, Prevention of venous thromboembolism in general surgical patients: results of mefa-analysis. Ann Surg 1988; 208:227-240
27. Mismetti P, Laporte S, Darmon JY, et al, Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001; 88:913-930
28. Wille-Jorgensen P, Rasmussen MD, Anderson BR, et al. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery, Cochrane Database Syst Rev 2004; (1): CD001217
29. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341:259-265
30. Nurmohamed MT, Verhaeghe R, Haas S, et al, A comparative trial of low molecular weight heparin(enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995; 169:567-571
31. Bergqvist D, Matzsch T, Burmark US, et al. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg 1988; 75:888-891
32. McLeod RS, Geerts WH, Sniderman KW, et al. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectai surgery: results of the Canadian Colorectai DVT Prophylaxis Trial: a randomized, double-blind trial, Ann Surg 2001; 233: 438-444
33. Koch A, Bouges S, Ziegler S, et al. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous metaanalysis. Br J Surg 1997; 84:750-759
34. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100:535-540
35. Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988; 72:925-930
36. Warkentin TE, Levine MN, Hirsh J, et al, Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin, N Engl J Med 1995; 332:1330-1335
37. Martel N, Lee J, Weils P. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylasxis: a meta-analysis. Blood 2005; 106:2710-2715
38. Samama MM, Gerotziafas GT. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide(fondaparinux). Thromb Res 2003; 109:1-11
39. Eriksson BI, Bauer KA, Lassen MR, Turpie AGG, for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345:1298-1304
40. Lassen MR, Bauer KA, Eriksson BI, Turpie AGG, for the European Pentasaccharide Hip Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002; 359; 1715-1720
41. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR, for the Steering Committees of the Pentasaccharide Orthopedic Prophylaxis Studies, Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162:1833-1840
42. Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M and PEGASUS Investigators. Randomised clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 2005; 92:1212-1220
43. Turpie AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE; Apollo investigators. Fondaparinox combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized double-blind comparison, J Thromb Haemost 2007; 5:1854-1861
44. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127:310-313
45. Lausen I, Jensen R, Jorgensen LN, et al. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomized controlled study of prolonged thromboprophylaxis, Eur J Surg 1998; 164:657-663
46. Bergqvist D, Angelli G, Cohen A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346:975-980
47. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter open-label study. J Thromb Haemost 2006; 4:2384-2390
48. National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing sugery, NICE clinical guideline No. 46:1-160. Available at: http://www.nice.org.uk/CG046. Accessed September 28, 2008